Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
24.7M
-
Number of holders
-
224
-
Total 13F shares, excl. options
-
22.2M
-
Shares change
-
-1.65M
-
Total reported value, excl. options
-
$3.34B
-
Value change
-
-$250M
-
Put/Call ratio
-
0.41
-
Number of buys
-
97
-
Number of sells
-
-117
-
Price
-
$150.60
Significant Holders of ICU MEDICAL INC/DE - Common Stock (ICUI) as of Q3 2022
268 filings reported holding ICUI - ICU MEDICAL INC/DE - Common Stock as of Q3 2022.
ICU MEDICAL INC/DE - Common Stock (ICUI) has 224 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.2M shares
of 24.7M outstanding shares and own 89.84% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (2.51M shares), T. Rowe Price Investment Management, Inc. (2.48M shares), WELLINGTON MANAGEMENT GROUP LLP (2.29M shares), VANGUARD GROUP INC (2.06M shares), BlackRock Inc. (1.73M shares), NUANCE INVESTMENTS, LLC (1.03M shares), JPMORGAN CHASE & CO (746K shares), STATE STREET CORP (572K shares), FULLER & THALER ASSET MANAGEMENT, INC. (537K shares), and Neuberger Berman Group LLC (380K shares).
This table shows the top 224 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.